Biodegradable microspheres containing influenza A vaccine: Immune response in mice

Vaccine

Volumn 17, Issue 9-10, 1999, Pages 1065-1073

  Hilbert, Anne K ^a   Fritzsche, Ulrike ^b   Kissel, Thomas ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b Preclinical Research   (Germany)

Author keywords

ABA triblock copolymers; Biodegradable microspheres; Influenza vaccine

Indexed keywords

INFLUENZA VACCINE; PHOSPHATIDYLCHOLINE; POLYVINYL ALCOHOL;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; DRUG EFFICACY; DRUG FORMULATION; DRUG SOLUBILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOGENICITY; INFECTION PREVENTION; INFLUENZA VIRUS A; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, VIRAL; BIOCOMPATIBLE MATERIALS; BIODEGRADATION, ENVIRONMENTAL; FEMALE; INFLUENZA A VIRUS; INFLUENZA VACCINES; LACTIC ACID; MICE; MICE, INBRED BALB C; MICROSPHERES; POLYGLYCOLIC ACID; POLYMERS;

EID: 0033525798     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00323-5     Document Type: Article

References (23)

1. Edwards K.M., Dupont W.D., Westrich M.K., Plummer W.D. Jr, Palmer P.S., Wright P.F. A randomized controlled trial of cold-adopted and inactivated vaccines for the prevention of influenza A viruses. J Infect Dis. 169:1994;68-76.
2. Morris W., Steinhoff M.C., Russel P.K. Potential of polymer microencapsulation technology for vaccine innovation. Vaccine. 12:1994;5-11.
3. 4 on purified influenza virus hemagglutinins in man. J Immunol. 100:1968;40-1139.
4. Skea D.L., Barber B.H. Adhesion-mediated enhancement of the adjuvant activity of alum. Vaccine. 11:1993;25-1018.
5. Esparza I., Kissel T. Parameters affecting the immunogenicity of microencapsulated tetanus toxoid. Vaccine. 10:1992;9-714.
6. Alonso M.J., Gupta R.K., Min C., Siber G.R., Langer R. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. Vaccine. 12:1994;299-306.
7. Chang A-C., Gupta R.K. Stabilization of tetanus toxoid in poly(DL-lactic-co-glycolic acid) microspheres for the controlled release of antigen. J Pharm Sci. 85:1996;32-129.
8. Lu W., Park T.G. Protein release from poly(lactic-co-glycolic acid) microspheres: protein stability problems. J Pharm Sci Technol. 49:1995;13-19.
9. Sluzky V., Tamada J.A., Klibanov A.M., Langer R. Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces. Proc Natl Acad Sci USA. 88:1991;81-9377.
10. Goepferich A. Polymer degradation and erosion: mechanisms and applications. Eur J Pharm Biopharm. 42:1996;1-11.
11. Li Y., Kissel T. Synthesis and properties of biodegradable ABA triblock copolymers consisting of poly(L-lactic acid) or poly(L-lactic-co-glycolic acid) A-blocks attached to central poly(oxyethylene) B-blocks. J Contr Rel. 27:1993;57-247.
12. Li Y., Volland C., Kissel T. In-vitro degradation and bovine serum albumin release of the ABA triblock copolymers consisting of poly(L(+) lactic acid), or poly(L(+)lactic-co-glycolic acid) A-blocks attached to central polyoxyethylene B-blocks. J Contr Rel. 32:1994;28-121.
13. El Guink N., Kris R.M., Goodman-Snitkoff G., Small P. Jr, Mannino R.J. Intranasal immunization with proteoliposomes protects against influenza. Vaccine. 7:1989;51-147.
14. De Haan A., Geerligs H.J., Huchshorn J.P., van Scharrenburg G.J.M., Palche A.M., Wilschut J. Mucosal immunoadjuvant activity of liposomes: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with an influenza subunit vaccine and coadministered liposomes. Vaccine. 13:1995;62-155.
15. Bodmer D., Kissel T., Traechslin E. Factors influencing the release of peptides and proteins from biodegradable parenteral depot systems. J Contr Rel. 21:1992;38-129.
16. Hunter W.M., Greenwood F.C. Preparation of iodine-131 labelled human growth hormone of highly specific activity. Nature. 194:1962;6-195.
17. Ogawa Y., Yamamoto M., Okada H., Yashiki T., Shimamoto T. A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid. Chem Pharm Bull. 36:1988;103-1095.
18. Kreuter J., Liehl E., Berg U., Soliva M., Speiser P.P. Influence of hydrophobicity on the adjuvant effect of particulate polymeric adjuvants. Vaccine. 6:1988;6-253.
19. Justewicz D.M., Doherty P.C., Webster R.G. The B-cell response in lymphoid tissue of mice immunized with various antigenic forms of the influenza virus hemagglutinin. J Virol. 69:1995;21-5414.
20. Moldoveanu Z., Novak M., Huang W-Q., Gilley R., Staas J.K., Schafer D., Compans R.W., Mestecky J. Oral immunization with influenza virus in biodegradable microspheres. J Infect Dis. 167:1993;84-90.
21. Med Lett Drugs Therap. 38:1996;86.
22. Beyer W.E.P., Palache A.M., Sprenger M.J.W., Hendriksen E., Tukker J.J., Darioli R., van der Water G.L., Masurel N., Osterhaus A.D.M.E. Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults. Vaccine. 14:1996;9-1331.
23. O'Hagan D.T., Jeffrey H., Roberts M.J.J., McGee J.P., Davis S.S. Controlled release microparticles for vaccine development. Vaccine. 9:1991;71-768.